Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer

British Journal of Cancer

Volumn 109, Issue 10, 2013, Pages 2533-2547

  Sutton, A J ^a   Barton, P ^a   Sundar, S ^a   Meads, C ^b   Rosenthal, A N ^b   Baldwin, P ^c   Khan, K ^b   Roberts, T E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DYE; TECHNETIUM 99M;

ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINOFEMORAL LYMPHADENECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MODEL; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PUBLICATION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; VULVA CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; INGUINAL CANAL; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 84887844541     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.631     Document Type: Article

References (20)

1. Barton P, Bryan S, Robinson S (2004) Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 9(2): 110-118.
2. Brennan A, Chick SE, Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies. Health Econ 15(12): 1295-1310.
3. Crosbie EJ, Winter-Roach B, Sengupta P, Sikand KA, Carrington B, Murby B, Slade RJ (2010) The accuracy of the sentinel node procedure after excision biopsy in squamous cell carcinoma of the vulva. Surg Oncol 19(4): e150-e154.
4. de Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, Aalders JG, Mourits MJ, van der Zee AG (2002) Vulvar carcinoma. The price of less radical surgery. Cancer 95(11): 2331-2338.
5. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, Aalders JG, van der Zee AG (2000) Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18(15): 2811-2816.
6. Devlin N, Parkin D (2004) Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13(5): 437-452.
7. Elit L, Voruganti S, Simunovic M (2005) Invasive vulvar cancer in a woman with human immunodeficiency virus: case report and review of the literature. Gynecol Oncol 98(1): 151-154.
8. Fonseca-Moutinho JA (2005) Recurrent vulvar cancer. Clin Obstet Gynecol 48(4): 879-883.
9. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S (2011) Applied Methods of Cost-effectiveness Analysis. 1st edn. Oxford University Press: Oxford.
10. Hacker NF (2005) 'Vulvar cancer, ' In Practical Gynaecologic Oncology, Berek JS, Hacker NF (eds) Williams & Wilkins: Philadelphia, PA, USA, pp 585-602.
11. Hampl M, Hantschmann P, Michels W, Hillemanns P (2008) Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 111(2): 282-288.
12. Macnab JC, Walkinshaw SA, Cordiner JW, Clements JB (1986) Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med 315(17): 1052-1058.
13. Meads C, Sutton AJ, Makysiak S, Kowalska M, Zapalska A, Rogozinska E, Baldwin P, Rosenthal A, Ganesan R, Borowiack E, Barton P, Roberts T, Sundar S, Khan K (2013) Sentinel lymph node (SLN) status in vulval cancer: Systematic quantitative reviews and decision analytic model-based economic evaluation. HTA. Available at http://www.hta.ac.uk/2338 (Accessed 18 September 2013).
14. Moore RG, Robison K, Brown AK, Disilvestro P, Steinhoff M, Noto R, Brard L, Granai CO (2008) Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol 109(1): 65-70.
15. Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, Van der Velden J, Hermans RH, van der Putten HW, Drouin P, Runnebaum IB, Sluiter WJ, van der Zee AG (2010a) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7): 646-652.
16. Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, Van der Velden J, Hermans RH, van der Putten HW, Drouin P, Runnebaum IB, Sluiter WJ, van der Zee AG (2010b) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7): 646-652.
17. Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG (2009) A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 113(3): 301-305.
18. Selman TJ (2009) Non-invasive and minimally invasive diagnosis and therapy of lymphadenopathy in gynaecological cancers-Systematic reviews of the evidence. PhD University of Birmingham, Birmingham, UK.
19. Selman T.J., Luesley D.M., Acheson N., Khan K.S., Mann C.H. (2005) A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol 99(1): 206-214.
20. van der Zee AG, Oonk MH, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6): 884-889.